Bioethics Stock Performance
| BOTH Stock | USD 0.01 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Bioethics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bioethics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Bioethics is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 667.00 | |
| Free Cash Flow | -27.5 K |
Bioethics |
Bioethics Relative Risk vs. Return Landscape
If you would invest 0.51 in Bioethics on November 30, 2025 and sell it today you would earn a total of 0.00 from holding Bioethics or generate 0.0% return on investment over 90 days. Bioethics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Bioethics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bioethics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bioethics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bioethics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bioethics generated a negative expected return over the last 90 days | |
| Bioethics has some characteristics of a very speculative penny stock | |
| Bioethics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (107.18 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations. | |
| Roughly 89.0% of the company shares are held by company insiders |
Bioethics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bioethics Pink Sheet often depends not only on the future outlook of the current and potential Bioethics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bioethics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Short Long Term Debt | 395.4 K | |
| Cash And Short Term Investments | 734.00 |
Bioethics Fundamentals Growth
Bioethics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bioethics, and Bioethics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioethics Pink Sheet performance.
| Return On Asset | -56.39 | |||
| Current Valuation | 647.72 K | |||
| Shares Outstanding | 1.14 M | |||
| Price To Book | 2,021 X | |||
| EBITDA | (59.14 K) | |||
| Cash And Equivalents | 554 | |||
| Total Debt | 398.53 K | |||
| Book Value Per Share | (0.58) X | |||
| Cash Flow From Operations | (27.48 K) | |||
| Earnings Per Share | (0.09) X | |||
| Total Asset | 734 | |||
About Bioethics Performance
By evaluating Bioethics' fundamental ratios, stakeholders can gain valuable insights into Bioethics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bioethics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bioethics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States.Things to note about Bioethics performance evaluation
Checking the ongoing alerts about Bioethics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bioethics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioethics generated a negative expected return over the last 90 days | |
| Bioethics has some characteristics of a very speculative penny stock | |
| Bioethics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (107.18 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations. | |
| Roughly 89.0% of the company shares are held by company insiders |
- Analyzing Bioethics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioethics' stock is overvalued or undervalued compared to its peers.
- Examining Bioethics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioethics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioethics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioethics' pink sheet. These opinions can provide insight into Bioethics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bioethics Pink Sheet analysis
When running Bioethics' price analysis, check to measure Bioethics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioethics is operating at the current time. Most of Bioethics' value examination focuses on studying past and present price action to predict the probability of Bioethics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioethics' price. Additionally, you may evaluate how the addition of Bioethics to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |